Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.291
Delayed Data
As of Apr 20
 -0.0085 / -2.84%
Today’s Change
0.29
Today|||52-Week Range
0.68
-18.83%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Cope Frederick O
Chief Scientific Officer & Senior Vice President
Gift2/20/2018135,694$0.36$48.8K-19.19%
Goldberg Michael M
President & Chief Executive Officer
Gift5/16/2017106,021$0.46$48.8K-36.74%
Regan William J
Senior Vice President
Buy6/29/201720,000$0.53$10.6K-43.53%
Latkin Jed Andrew
Chief Operating & Financial Officer
Buy5/19/201714,159$0.45$6.4K-36.10%
Latkin Jed Andrew
Chief Operating & Financial Officer
Gift5/17/201713,300$0.47$6.3K-36.24%
Latkin Jed Andrew
Chief Operating & Financial Officer
Buy5/22/201711,200$0.45$5.0K-35.26%
Latkin Jed Andrew
Chief Operating & Financial Officer
Buy5/30/20177,600$0.44$3.3K-35.33%
Latkin Jed Andrew
Chief Operating & Financial Officer
Gift5/18/20173,900$0.45$1.8K-35.59%
Fiorino Anthony S
Director
Gift6/30/201750,000$0.00$0.00-42.94%
Greene Mark I
Director
Gift6/30/201750,000$0.00$0.00-42.94%
Page of 2